Central blood pressure reflects left ventricular load, while brachial blood pressure reflects arterial damage

Blood Pressure

Volumn 23, Issue 6, 2014, Pages 356-362

  Yamashita, Sumiyo ^a   Dohi, Yasuaki ^a   Takase, Hiroyuki ^b   Sugiura, Tomonori ^a   Ohte, Nobuyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Enshu Hospital   (Japan)

Author keywords

B type natriuretic peptide; Carotid arteries; Intima media thickness; Target organ damage; Ventricular load

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRACHIAL BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; CENTRAL BLOOD PRESSURE; CORRELATION ANALYSIS; FEMALE; HEART LEFT VENTRICLE PRESSURE; HUMAN; HUMAN EXPERIMENT; LATE SYSTOLIC PEAK PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PULSE WAVE; RADIAL ARTERY; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS; AGED; BLOOD; BRACHIAL ARTERY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; HEART VENTRICLE; HEART VENTRICLE FUNCTION; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR FUNCTION;

EID: 84910625227     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2014.923250     Document Type: Article

References (37)

1. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet. 2003;362: 1527-1535.
2. Schmieder RE, Lehmann MV, Schmidt S. Optimizing blood pressure control in hypertension: The need to use ABPM. Blood Press. 2013;22:65-72.
3. Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: Ameta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
4. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al.; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113: 1213-1225.
5. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension. 2007;50:197-203.
6. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: Which best relates to target organs and future mortality? J Hypertens 2009;27:461-467.
7. Masugata H, Senda S, Okuyama H, Murao K, Inukai M, Hosomi N, et al. Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. Hypertens Res. 2009;32:1136-1142.
8. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, et al. Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens. 2011;29:454-459.
9. O'Rourke M. Mechanical principles in arterial disease. Hypertension. 1995;26:2-9.
10. Mitchell GF, Lacourcière Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: The role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108: 1592-1598.
11. Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004;19:341-352.
12. Takazawa K, Tanaka N, Takeda K, Kurosu F, Ibukiyama C. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension. 1995;26: 520-523.
13. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of amethod for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001; 38:932-937.
14. O'Rourke MF, Nichols WW. Potential for use of pulse wave analysis in determining the interaction between sildenafil and glyceryl trinitrate. Clin Cardiol. 2002;25:295-299.
15. Gallagher D, Adji A, O'Rourke MF. Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens. 2004;17: 1059-1067.
16. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': Beyond blood pressure or beyond the brachial artery? J Hypertens. 2005;23:551-556.
17. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res. 2007;30:219-228.
18. Takase H, Dohi Y, Kimura G. Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population. Hypertens Res. 2013;36:50-57.
19. Hickson SS, Butlin M, Mir FA, Graggaber J, Cheriyan J, Khan F, et al. Anglo-Cardiff Collaboration Trial Investigators. The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform. J Hyper-tens. 2009;27:1784-1788.
20. Takazawa K, Kobayashi H, Kojima I, Aizawa A, Kinoh M, Sugo Y, et al. Estimation of central aortic systolic pressure using late systolic inflection of radial artery pulse and its application to vasodilator therapy. J Hypertens. 2012;30: 908-916.
21. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: Aconsensus document. Hypertension. 2007;50:154-160.
22. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, et al. Differential effects between acalcium channel blocker and adiuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54:716-723.
23. Boutouyrie P, Achouba A, Trunet P, Laurent S; EXPLOR Trialist Group. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: The EXPLOR study. Hypertension. 2010;55:1314-1322.
24. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as anovel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87: 1402-1412.
25. Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, et al. Measurement of plasma brain natriuretic peptide level as aguide for cardiac overload. Cardiovasc Res. 2001;51:585-591.
26. Takase H, Toriyama T, Sugiura T, Takahashi A, Sugiyama M, Ohashi M, et al. Brain natriuretic peptide detects cardiac abnormalities in mass screening. Eur J Clin Invest. 2007;37:257-262.
27. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, et al. Human brain natriuretic peptide, anovel cardiac hormone. Lancet. 1990;335:801-802.
28. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens. 1993;7:245-250.
29. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Lond). 1998;95:519-529.
30. Jakubik P, Janota T, Widimsky J Jr, Zelinka T, Strauch B, Petrak O, et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press. 2006;15:302-307.
31. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630.
32. Edwards DG, Gauthier AL, Hayman MA, Lang JT, Kenefick RW. Acute effects of cold exposure on central aortic wave reflection. J Appl Physiol. 2006;100:1210-1214.
33. Wojciechowska W, Stolarz-Skrzypek K, Tikhonoff V, Richart T, Seidlerova J, Cwynar M, et al.; European Project On Genes In Hypertension (Epogh) Investigators. Age dependency of central and peripheral systolic blood pressures: Cross-sectional and longitudinal observations in European populations. Blood Press. 2012;21:58-68.
34. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang YL, Berry KL, et al. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension. 2007;49:1242-1247.
35. Hope SA, Antonis P, Adam D, Cameron JD, Meredith IT. Arterial pulse wave velocity but not augmentation index is associated with coronary artery disease extent and severity: Implications for arterial transfer function applicability. J Hypertens. 2007;25:2105-2109.
36. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: Asystematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871.
37. Richardson CJ, Maki-Petaja KM, McDonnell BJ, Hickson SS, Wilkinson IB, McEniery CM. Comparison of estimates of central systolic blood pressure and peripheral augmentation index obtained from the Omron HEM-9000AI and Sphyg-moCor systems. Artery Res. 2009;3:24-31.